News Image

BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements

Provided By GlobeNewswire

Last update: Sep 18, 2025

NEW HAVEN, Conn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the market value of listed securities (“MVLS”) requirement under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”).

Read more at globenewswire.com

BIOXCEL THERAPEUTICS INC

NASDAQ:BTAI (10/9/2025, 4:31:46 PM)

After market: 2.7796 0 (-0.01%)

2.78

+0.12 (+4.51%)



Find more stocks in the Stock Screener

Follow ChartMill for more